Forum for Science, Industry and Business

The European Commission launches a strategy to reduce diseases linked to environmental factors

There is a strong link between poor health and environmental problems. A recent report from the European Environmental Agency, EEA, shows that as many as 60 000 deaths per year in large European cities are caused by long-term exposure to air pollution. Children are more exposed to environmental risks than adults.

One child in seven is affected by asthma. Compared to 30 years ago this is a dramatic increase. In order to reverse this alarming trend the European Commission is today launching A European Environment and Health Strategy. With this new strategy the Commission expects to achieve a better understanding of the complex relationship between environment and health and to identify and reduce diseases caused by environmental factors.

The new strategy on Environment and Health is a long-term vision. The overall aim of the strategy is to reduce diseases caused by environmental factors in Europe. In order to achieve this goal we have to better understand and identify health problems related to environmental degradation, which will allow us to prevent new health threats linked to environmental pollution. Special emphasis will be given to the most vulnerable groups in society, in particular children.

• It will be based on Science to broaden our perspective on the often very complex link between environment and health. Traditionally, environmental assessments and policy action have focused on single pollutants in single environmental compartments, such as air, water or soil. There is, however,a strong need to look into how different pollutant react together. We need to understand better how pollutants move in the environment and how we come in contact with them - through air, water, food, and consumer products. We also need to understand how the human body reacts, over a period of time, to the continuous exposure to different pollutants, inter-acting between each others, often at a low level.
  
  
• We will focus on Children since they are particularly vulnerable to environmental hazards. There are 157 million children in Europe. Most of them live in urban areas with particular environmental problems that must be addressed. The Commission will be launching pilot actions on pollutants with specific relevance to children, including dioxins, heavy metals and endocrine disrupters (chemicals that affect the hormone system). Together with the World Health Organization, WHO, and the EU Member States, we will establish indicators and bio-monitoring systems that will help us better to understand where, how and why children are affected.
  
  
• We have to raise Awareness of the environmental-health problems and how they can be solved. Citizens have the right to know about these problems, in particular those affecting children. Policy-makers and stakeholders from both the environmental and health sector must increase their efforts to communicate, both across the sectors and with the citizens.
  
  
• The EU Legislation will complement national and international initiatives. It will be reviewed to reflect the special situation and needs of children.
  
  
• All actions taken under the strategy will be Evaluated continuously. We will verify how effective they are in reducing environmental-related health problems. A constant evaluation will also allow us to address new problems as they emerge.

Four priority health effects

The European Environment and Health Strategy will be implemented in cycles. The first cycle, 2004 - 2010, will focus on four health effects:

• Childhood respiratory diseases, asthma, allergies
  
• Neurodevelopment disorders
  
• Childhood cancer
  
• Endocrine disrupting effects

What happens next?

The detailed actions of the strategy will be prepared based on extensive consultations with experts and stakeholders from the environment, health and research fields in all parts of the enlarged Europe. A first stakeholder meeting will take place on 11 July in Brussels to launch the consultations. Working groups covering the priority health effects and monitoring activities will be set up and participate in three regional conferences during Autumn 2003. The work will emanate in an Action Plan for the period 2004-2010, which the Commission will adopt in spring 2004. The Action Plan will be presented prior to the Inter-Ministerial Conference on Environment and Health in Budapest in June 2004, focusing particularly on children’s health and environment.

Background information

Throughout Europe 10% of the children suffer from asthmatic symptoms. Asthma, allergies and other respiratory diseases are one of the main reasons for hospital treatment of children. Also less common diseases, caused by environmental factors, are increasing like leukaemia, which is the most common form of childhood cancer. Many pollutants, including dioxins, are dangerous even before birth. They can reach the foetus in the womb and increase the risk of miscarriage and birth defects. In some parts of Europe, up to 10% of infants develop mental or physical disabilities. These disabilities are blamed on exposure to lead, mercury and certain chemicals. Chemicals, like endocrine disrupters, can also act like hormones and disrupt the way the body functions, with adverse effects on reproductive capacity.

Children are particularly vulnerable to environmental pollution and can not be considered as “small adults”. They are particularly exposed to toxins in water, food and air because they drink more water, eat more food and breathe more air than adults relative to body volume. They also absorb more of the content of what they eat. While adults absorb 10% of any lead in food, children absorb 40%.

Furthermore, their nervous, respiratory and reproductive systems are not yet fully developed. This makes them less able to excrete certain toxins. Children are also particularly exposed to ground level car emissions. As children spend much time close to the ground and put their hands in their mouths it further increase their exposure to toxicants in dust and soil.

| European Commission
Further information:
http://www.who.int
http://www.eea.eu.int
http://www.tvlink.org

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

Im Focus: New double-contrast technique picks up small tumors on MRI

Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.

researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...

Im Focus: I-call - When microimplants communicate with each other / Innovation driver digitization - "Smart Health“

Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.

When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...

Im Focus: When predictions of theoretical chemists become reality

Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.

Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...

Im Focus: Rolling into the deep

Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.

A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...